Skip to main content

Vascular Diseases – Peripheral/Aorta

  • Chapter
  • First Online:
Manual of Outpatient Cardiology

Abstract

Peripheral arterial disease (PAD) is a common yet vastly underdiagnosed condition that is associated with substantial morbidity and mortality. Because atherosclerosis is a systemic disease, the presence of PAD, whether symptomatic or not, is associated with a two- to fourfold increase in the risk of myocardial infarction, stroke and cardiovascular death [1–3]. More timely diagnosis of PAD in the primary care setting has the potential not only to improve quality of life by helping to alleviate the lifestyle-impairing symptoms often associated with the disease, but also to identify individuals at high risk for cardiac and cerebrovascular events providing the opportunity to initiate effective life-saving therapies at an earlier stage [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ankle Brachial Index C. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.

    Article  Google Scholar 

  2. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114(7):688–99.

    Article  PubMed  Google Scholar 

  3. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–61.

    Article  PubMed  Google Scholar 

  4. Perlstein TS, Creager MA, Perlstein TS, Creager MA. The ankle-brachial index as a biomarker of cardiovascular risk: it’s not just about the legs. Circulation. 2009;120(21):2033–5.

    Article  PubMed  Google Scholar 

  5. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    Article  PubMed  CAS  Google Scholar 

  6. White C. Intermittent claudication. N Engl J Med. 2007;356(12):1241–50.

    Article  PubMed  CAS  Google Scholar 

  7. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.

    Article  PubMed  CAS  Google Scholar 

  8. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation. 1995;92(3):614–21.

    PubMed  CAS  Google Scholar 

  9. Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg. 2010;51(1):230–41.

    Article  PubMed  Google Scholar 

  10. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.

    Article  PubMed  Google Scholar 

  11. McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med. 1998;158(12):1357–64.

    Article  PubMed  CAS  Google Scholar 

  12. Cheer K, Shearman C, Jude EB. Managing complications of the diabetic foot. BMJ. 2009;339:1304–7.

    Google Scholar 

  13. Grenon SM, Gagnon J, Hsiang Y, Grenon SM, Gagnon J, Hsiang Y. Video in clinical medicine. Ankle-brachial index for assessment of peripheral arterial disease. N Engl J Med. 2009;361(19):e40.

    Article  PubMed  CAS  Google Scholar 

  14. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med. 2001;18(7):528–32.

    Article  PubMed  CAS  Google Scholar 

  15. Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med. 2006;11(1):29–33.

    Article  PubMed  Google Scholar 

  16. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improve­ment Initiative (PVD-QI2). Circulation. 2002;106(15):1909–12.

    Article  PubMed  Google Scholar 

  17. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease. Circulation. 2006;113(11):e463–654.

    Article  PubMed  Google Scholar 

  18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

    Article  PubMed  CAS  Google Scholar 

  19. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753–6.

    Article  PubMed  Google Scholar 

  20. Heart Protection Study Collaborative G. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645–54.

    Article  Google Scholar 

  21. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301(18):1909–19.

    Article  PubMed  CAS  Google Scholar 

  22. Clagett GP, Sobel M, Jackson MR, Lip GY, Tangelder M, Verhaeghe R. Antithrombotic therapy in peripheral arterial occlusive disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):609S–26.

    Article  PubMed  CAS  Google Scholar 

  23. McDermott MM, Criqui MH. Aspirin and secondary prevention in peripheral artery disease: a perspective for the early 21st century. JAMA. 2009;301(18):1927–8.

    Article  PubMed  CAS  Google Scholar 

  24. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25(1):17–24.

    Article  PubMed  CAS  Google Scholar 

  25. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145–53.

    Article  PubMed  CAS  Google Scholar 

  26. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med. 1991;151(9):1769–76.

    Article  PubMed  CAS  Google Scholar 

  27. Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004;164(4):440–6.

    Article  PubMed  Google Scholar 

  28. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165–74.

    Article  PubMed  CAS  Google Scholar 

  29. Chi YW, Lavie CJ, Milani RV, White CJ. Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag. 2008;4(6):1197–203.

    PubMed  CAS  Google Scholar 

  30. Mahmud E, Cavendish JJ, Salami A. Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol. 2007;50(6):473–90.

    Article  PubMed  CAS  Google Scholar 

  31. Dworkin LD, Cooper CJ. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972–8.

    Article  PubMed  CAS  Google Scholar 

  32. Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol. 2008;23(6):527–36.

    Article  PubMed  Google Scholar 

  33. ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.

    Article  Google Scholar 

  34. George JC, White CJ. Renal artery stenting: lessons from ASTRAL (Angioplasty and Stenting for Renal Artery Lesions). JACC Cardiovasc Interv. 2010;3(7):786–7.

    Article  PubMed  Google Scholar 

  35. Sixt S, Rastan A, Schwarzwalder U, Burgelin K, Noory E, Schwarz T, et al. Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction. Catheter Cardiovasc Interv. 2009;73(3):395–403.

    Article  PubMed  Google Scholar 

  36. Metcalfe D, Holt PE, Thompson M. The management of abdominal aortic aneurysms. BMJ. 2011;342:644–9.

    Article  Google Scholar 

  37. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the society for vascular surgery practice guidelines. J Vasc Surg. 2009;50(4 Suppl):S2–49.

    Article  PubMed  Google Scholar 

  38. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice G. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease. Circulation. 2010;121(13):e266–369.

    Article  PubMed  Google Scholar 

  39. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg. 2011;41 Suppl 1:S1–58.

    Article  PubMed  Google Scholar 

  40. Greenhalgh RM, Powell JT. Endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2008;358(5):494–501.

    Article  PubMed  CAS  Google Scholar 

  41. Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372(9632):55–66.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Craig R. Narins .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Narins, C.R., Pacos, J.D., Hirokawa, T.I. (2012). Vascular Diseases – Peripheral/Aorta. In: Bisognano, J., Beck, R., Connell, R. (eds) Manual of Outpatient Cardiology. Springer, London. https://doi.org/10.1007/978-0-85729-944-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-944-4_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-943-7

  • Online ISBN: 978-0-85729-944-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics